Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma

por Feugier, Pierre, Filliatre-Clement, Lauriane
Publicado 2019

Patients with Persistent Polyclonal B-Cell Lymphocytosis Share the Symptomatic Criteria of Systemic Exertion Intolerance Disease

por Morizot, Romain, de Korwin, Jean-Dominique, Feugier, Pierre, Broséus, Julien, Troussard, Xavier, Lesesve, Jean-François
Publicado 2021

Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count

por Divoux, Marion, Plocque, Alexia, Sevin, Margaux, Voillat, Laurent, Feugier, Pierre, Guerci‐Bresler, Agnès, Girodon, Francois, Broséus, Julien
Publicado 2020

Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome

por Augé, Hélène, Notarantonio, Anne-Béatrice, Morizot, Romain, Quinquenel, Anne, Fornecker, Luc-Matthieu, Hergalant, Sébastien, Feugier, Pierre, Broséus, Julien
Publicado 2020

Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma

por Hazane Leroyer, Esther, Ziegler, Caroline, Moulin, Charline, Campidelli, Arnaud, Jacquet, Caroline, Rubio, Marie Thérèse, Feugier, Pierre, Pagliuca, Simona
Publicado 2022

Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses

por Broséus, Julien, Chen, Gaili, Hergalant, Sébastien, Ramstein, Gérard, Mounier, Nicolas, Guéant, Jean-Louis, Feugier, Pierre, Gisselbrecht, Christian, Thieblemont, Catherine, Houlgatte, Rémi
Publicado 2016

Primary Epicardial Malt Lymphoma: A New Physiopathologic Entity Mimicking a Pericardial Compressive Syndrome

por Grandmougin, Daniel, Bouhlel, Mahmoud Cheikh, Lardenois, Emilie, Donaint, Pierre, Benigni, Paolo, Sbaffi, Alessandra, Sirbu, Christina, Feugier, Pierre, Touati, Rabea, Maureira, Juan-Pablo
Publicado 2021

Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia

por Cornet, Edouard, Delmer, Alain, Feugier, Pierre, Garnache-Ottou, Francine, Ghez, David, Leblond, Véronique, Levy, Vincent, Maloisel, Frédéric, Re, Daniel, Zini, Jean-Marc, Troussard, Xavier
Publicado 2014

P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERON...

por Ysebaert, Loïc, Troussard, Xavier, Levy, Vincent, Le Calloch, Ronan, Guieze, Romain, Laribi, Kamel, Lepretre, Stephane, Sophie Michallet, Anne, Leblond, Véronique, Feugier, Pierre, Lahjibi, Elhem, Ramier, Julien, Delmer, Alain
Publicado 2023

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation

por Pagliuca, Simona, Gurnari, Carmelo, Hercus, Colin, Hergalant, Sébastien, Hong, Sanghee, Dhuyser, Adele, D’Aveni, Maud, Aarnink, Alice, Rubio, Marie Thérèse, Feugier, Pierre, Ferraro, Francesca, Carraway, Hetty E., Sobecks, Ronald, Hamilton, Betty K., Majhail, Navneet S., Visconte, Valeria, Maciejewski, Jaroslaw P.
Publicado 2023

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation

por Pagliuca, Simona, Gurnari, Carmelo, Hercus, Colin, Hergalant, Sébastien, Hong, Sanghee, Dhuyser, Adele, D’Aveni, Maud, Aarnink, Alice, Rubio, Marie Thérèse, Feugier, Pierre, Ferraro, Francesca, Carraway, Hetty E., Sobecks, Ronald, Hamilton, Betty K., Majhail, Navneet S., Visconte, Valeria, Maciejewski, Jaroslaw P.
Publicado 2023

Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

por Camus, Vincent, Belot, Aurélien, Oberic, Lucie, Sibon, David, Ghesquières, Hervé, Thieblemont, Catherine, Fruchart, Christophe, Casasnovas, Olivier, Michot, Jean-Marie, Molina, Thierry Jo, Bosly, André, Joubert, Clémentine, Haioun, Corinne, Nicolas-Virelizier, Emmanuelle, Feugier, Pierre, Fitoussi, Olivier, Delarue, Richard, Tilly, Hervé
Publicado 2022

Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells

por Galtier, Jean, Vercellino, Laetitia, Chartier, Loic, Olivier, Pierre, Tabouret-Viaud, Claire, Mesguich, Charles, Di Blasi, Roberta, Durand, Amandine, Raffy, Léo, Gros, François-Xavier, Madelaine, Isabelle, Meignin, Veronique, Mebarki, Miryam, Rubio, Marie-Thérèse, Feugier, Pierre, Casasnovas, Olivier, Meignan, Michel, Thieblemont, Catherine
Publicado 2022

P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY

por Delfau-Larue, Marie-Helene, Gomes, Lucie, Cartron, Guillaume, Morschhauser, Franck, Gros, Francois-Xavier, Gastinne, Thomas, Oberic, Lucie, Bachy, Emmanuel, Feugier, Pierre, Duléry, Rémy, Menard, Cedric, Pangault, Celine, Claudel, Alexis, Quelen, Cathy, Portugues, Cedric, Viailly, Pierre-Julien, Lemonnier, Francois, Itti, Emmanuel, Bailly, Clément, Laurent, Camille, Houot, Roch
Publicado 2023

High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline

por Rossi, Cédric, André, Marc, Dupuis, Jehan, Morschhauser, Franck, Joly, Bertrand, Lazarovici, Julien, Ghesquières, Hervé, Stamatoullas, Aspasia, Nicolas-Virelizier, Emmanuelle, Feugier, Pierre, Gac, Anne-Claire, Moatti, Hannah, Fornecker, Luc-Matthieu, Deau, Bénédicte, Joubert, Clémentine, Fortpied, Catherine, Raemaekers, John, Federico, Massimo, Kanoun, Salim, Meignan, Michel, Traverse-Glehen, Alexandra, Cottereau, Anne-Ségolène, Casasnovas, René-Olivier
Publicado 2022

Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)

por Quinquenel, Anne, Aurran-Schleinitz, Thérèse, Clavert, Aline, Cymbalista, Florence, Dartigeas, Caroline, Davi, Frédéric, de Guibert, Sophie, Delmer, Alain, Dilhuydy, Marie-Sarah, Feugier, Pierre, Fornecker, Luc-Matthieu, Ghez, David, Guieze, Romain, Laribi, Kamel, Leblond, Véronique, Leprêtre, Stéphane, Letestu, Rémi, Lévy, Vincent, Nguyen-Khac, Florence, Michallet, Anne-Sophie, Tomowiak, Cécile, Tournilhac, Olivier, Ysebaert, Loïc, Troussard, Xavier
Publicado 2020

Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years

por Jullien, Maxime, Tessoulin, Benoit, Ghesquières, Hervé, Oberic, Lucie, Morschhauser, Franck, Tilly, Hervé, Ribrag, Vincent, Lamy, Thierry, Thieblemont, Catherine, Villemagne, Bruno, Gressin, Rémy, Bouabdallah, Kamal, Haioun, Corinne, Damaj, Gandhi, Fornecker, Luc-Matthieu, Schiano De Colella, Jean-Marc, Feugier, Pierre, Hermine, Olivier, Cartron, Guillaume, Bonnet, Christophe, André, Marc, Bailly, Clément, Casasnovas, René-Olivier, Le Gouill, Steven
Publicado 2021

Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)

por Algrin, Caroline, Pérol, Louis, Chapiro, Elise, Baseggio, Lucile, Maloum, Karim, Settegrana, Catherine, Lesesve, Jean-François, Siavellis, Justine, Delmer, Alain, Michallet, Anne-Sophie, Ferrant, Emmanuelle, Feugier, Pierre, Tomowiak, Cécile, Brion, Annie, Ghez, David, Fornecker, Luc-Matthieu, Ivanoff, Sarah, Struski, Stéphanie, Sutton, Laurent, Radford-Weiss, Isabelle, Eclache, Virginie, Lefebvre, Christine, Leblond, Véronique, Nguyen-Khac, Florence, Roos-Weil, Damien
Publicado 2022

S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY

por Houot, Roch, Bachy, Emmanuel, Cartron, Guillaume, Gros, Francois-Xavier, Morschhauser, Franck, Oberic, Lucie, Gastinne, Thomas, Feugier, Pierre, Duléry, Rémy, Thieblemont, Catherine, Joris, Magalie, Jardin, Fabrice, Choquet, Sylvain, Casasnovas, Rene Olivier, Brisou, Gabriel, Cheminant, Morgane, Bay, Jacques Olivier, Llamas, Francisco, Menard, Cedric, Tarte, Karin, Delfau-Larue, Marie-Helene, Itti, Emmanuel, Bailly, Clément, Al Tabaa, Yassine, Laurent, Camille, Lemonnier, Francois
Publicado 2023

Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

por Houot, Roch, Bachy, Emmanuel, Cartron, Guillaume, Gros, François-Xavier, Morschhauser, Franck, Oberic, Lucie, Gastinne, Thomas, Feugier, Pierre, Duléry, Rémy, Thieblemont, Catherine, Joris, Magalie, Jardin, Fabrice, Choquet, Sylvain, Casasnovas, Olivier, Brisou, Gabriel, Cheminant, Morgane, Bay, Jacques-Olivier, Gutierrez, Francisco Llamas, Menard, Cédric, Tarte, Karin, Delfau, Marie-Hélène, Portugues, Cédric, Itti, Emmanuel, Palard-Novello, Xavier, Blanc-Durand, Paul, Al Tabaa, Yassine, Bailly, Clément, Laurent, Camille, Lemonnier, François
Publicado 2023